These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 8970458)
1. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group. Gallagher RM Arch Neurol; 1996 Dec; 53(12):1285-91. PubMed ID: 8970458 [TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators. Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172 [TBL] [Abstract][Full Text] [Related]
3. Dihydroergotamine nasal spray for the acute treatment of migraine. Ziegler D; Ford R; Kriegler J; Gallagher RM; Peroutka S; Hammerstad J; Saper J; Hoffert M; Vogel B; Holtz N Neurology; 1994 Mar; 44(3 Pt 1):447-53. PubMed ID: 8145914 [TBL] [Abstract][Full Text] [Related]
4. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501 [TBL] [Abstract][Full Text] [Related]
5. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235 [TBL] [Abstract][Full Text] [Related]
6. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Winner P; Ricalde O; Le Force B; Saper J; Margul B Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069 [TBL] [Abstract][Full Text] [Related]
7. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326 [TBL] [Abstract][Full Text] [Related]
8. Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. Derry CJ; Derry S; Moore RA Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009663. PubMed ID: 22336867 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. Aurora SK; Rozen TD; Kori SH; Shrewsbury SB Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249 [TBL] [Abstract][Full Text] [Related]
10. Sumatriptan. An updated review of its use in migraine. Perry CM; Markham A Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601 [TBL] [Abstract][Full Text] [Related]
11. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341 [TBL] [Abstract][Full Text] [Related]
12. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M; Aschoff J; May A; Charlesworth BR; Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [TBL] [Abstract][Full Text] [Related]